Valuation: Phosphagenics Limited

Market Cap 68.95M 47.61M 41.74M 38.48M 36.02M 67.55M 4.49B 462M 179M 2.22B 179M 175M 7.7B P/E 2024
-2.5x
P/E 2025 -6.43x
Enterprise Value 64.3M 44.4M 38.93M 35.88M 33.59M 62.99M 4.19B 431M 167M 2.07B 167M 163M 7.18B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
75.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/05/2020
Chief Operating Officer - 01/05/2020
Corporate Secretary - 01/05/2026
Director TitleAgeSince
Director/Board Member - 13/04/2015
Chairman - 01/01/2019
Director/Board Member 59 26/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 47.61M
+7.13%+9.97%+55.80%+163.38% 1,077B
+3.99%+11.50%+67.09%+56.27% 613B
+4.20%+17.03%+38.97%+91.19% 448B
+0.99%+4.85%+28.17%+22.04% 332B
+1.82%+8.19%+40.04%+27.45% 293B
+0.22%+6.75%+31.30%+42.64% 286B
+0.73%+8.53%-27.33%-40.29% 215B
+1.56%+6.14%+29.30%+61.91% 193B
+3.26%+3.33%+15.55%+67.87% 159B
Average +0.96%+8.48%+30.99%+54.72% 401.79B
Weighted average by Cap. +3.85%+9.65%+41.75%+81.02%

Financials

2024 2025
Net sales 1.13M 782K 686K 632K 592K 1.11M 73.77M 7.6M 2.94M 36.46M 2.94M 2.87M 126M 1.24M 855K 749K 691K 647K 1.21M 80.62M 8.3M 3.21M 39.84M 3.21M 3.14M 138M
Net income -3.12M -2.16M -1.89M -1.74M -1.63M -3.06M -203M -20.94M -8.1M -101M -8.09M -7.92M -348M -4.42M -3.05M -2.67M -2.46M -2.31M -4.33M -288M -29.62M -11.46M -142M -11.45M -11.2M -493M
Net Debt -1.3M -896K -786K -724K -678K -1.27M -84.53M -8.71M -3.37M -41.78M -3.36M -3.29M -145M -4.65M -3.21M -2.81M -2.59M -2.43M -4.55M -303M -31.18M -12.07M -150M -12.05M -11.79M -519M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-